Daito Pharmaceutical Co.,Ltd.
4577・Prime Market・Pharmaceuticals
Daito Pharmaceutical Co.,Ltd.4577
Recent Disclosures
| Date | Type | Title |
|---|---|---|
| 2026-07-15 | Other | FY2026 4Q Earnings Presentation |
| 2026-07-15 | Other | 2026年5月期 決算説明資料 |
| 2026-07-13 | Other | 自己株式立会外買付取引(ToSTNeT-3)による自己株式の取得結果及び自己株式の取得終了に関するお知らせ |
| 2026-07-13 | Other | Notice Regarding the Results and Completion of the Acquisition of Treasury Shares Through Off-Auction Own Share Repurchase Transaction (ToSTNet-3) |
| 2026-07-10 | Other | Summary of Consolidated Financial Results for the Fiscal Year Ended May 31,2026 (Under Japanese GAAP) |
| 2026-07-10 | Other | 組織再編に関するお知らせ |
| 2026-07-10 | Other | Notice Regarding Changes in Representative Director and Executive Officers and Nomination of New Director Candidates |
| 2026-07-10 | Other | 代表取締役の異動及び新任取締役候補者の選任ならびに執行役員の異動に関するお知らせ |
| 2026-07-10 | Earnings Report | 2026年5月期 決算短信〔日本基準〕(連結) |
| 2026-07-10 | Other | Notice Regarding Acquisition of Treasury Shares through ToSTNeT-3 |